메뉴 건너뛰기




Volumn 29, Issue 4, 2011, Pages

Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MOLECULAR MARKER; PROGESTERONE RECEPTOR; PROTEIN P16; TUMOR MARKER;

EID: 79952088414     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6850     Document Type: Letter
Times cited : (11)

References (13)
  • 1
    • 77957255815 scopus 로고    scopus 로고
    • Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ
    • Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 3762-3769
    • Rudloff, U.1    Jacks, L.M.2    Goldberg, J.I.3
  • 2
    • 70350092772 scopus 로고    scopus 로고
    • NCCN task force report: Estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry
    • suppl 6
    • Allred DC, Carlson RW, Berry DA, et al: NCCN task force report: Estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw 7:S1-S23, 2009 (suppl 6)
    • (2009) J Natl Compr Canc Netw , vol.7
    • Allred, D.C.1    Carlson, R.W.2    Berry, D.A.3
  • 3
    • 77954526150 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • Hammond ME, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3
  • 5
    • 0027994342 scopus 로고
    • Mammographically-detected ductal in situ carcinoma of the breast analysed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity
    • Zafrani B, Leroyer A, Fourquet A, et al: Mammographically-detected ductal in situ carcinoma of the breast analysed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol 11:208-214, 1994
    • (1994) Semin Diagn Pathol , vol.11 , pp. 208-214
    • Zafrani, B.1    Leroyer, A.2    Fourquet, A.3
  • 7
    • 0030037187 scopus 로고    scopus 로고
    • Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: Correlation with morphological features and recently proposed schemes for histological classification
    • DOI 10.1016/S0960-9776(96)90054-5
    • Millis RR, Bobrow LG, Barnes DM: Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: Correlation with morphological features and recently proposed schemes for histological classification. Breast 5:113-122, 1996 (Pubitemid 26234097)
    • (1996) Breast , vol.5 , Issue.3 , pp. 113-122
    • Millis, R.R.1    Bobrow, L.G.2    Barnes, D.M.3
  • 8
    • 0028931870 scopus 로고
    • Loss of heterozygosity in ductal carcinoma in situ of the breast
    • Stratton MR, Collins N, Lakhani SR, et al: Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175:195-201, 1995
    • (1995) J Pathol , vol.175 , pp. 195-201
    • Stratton, M.R.1    Collins, N.2    Lakhani, S.R.3
  • 10
    • 77952054026 scopus 로고    scopus 로고
    • Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
    • Kerlikowske K, Molinaro AM, Gauthier ML, et al: Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102:627-637, 2010
    • (2010) J Natl Cancer Inst , vol.102 , pp. 627-637
    • Kerlikowske, K.1    Molinaro, A.M.2    Gauthier, M.L.3
  • 11
    • 0034930801 scopus 로고    scopus 로고
    • Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
    • DOI 10.1053/ejso.2000.1062
    • Bijker N, Rutgers EJ, Peterse JL, et al: Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 27:135-140, 2001 (Pubitemid 32621723)
    • (2001) European Journal of Surgical Oncology , vol.27 , Issue.2 , pp. 135-140
    • Bijker, N.1    Rutgers, E.J.T.2    Peterse, J.L.3    Fentiman, I.S.4    Julien, J.-P.5    Duchateau, L.6    Van, D.J.A.7
  • 12
    • 0031888111 scopus 로고    scopus 로고
    • Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast
    • American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology
    • Winchester DP, Strom EA: Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology CA Cancer J Clin 48:108-128, 1998
    • (1998) CA Cancer J Clin , vol.48 , pp. 108-128
    • Winchester, D.P.1    Strom, E.A.2
  • 13
    • 0033744928 scopus 로고    scopus 로고
    • Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted?
    • Lee CH, Carter D, Philpotts LE, et al: Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted? Radiology 217:466-470, 2000
    • (2000) Radiology , vol.217 , pp. 466-470
    • Lee, C.H.1    Carter, D.2    Philpotts, L.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.